4.6 Article

Phosphorylation of Histone H3 by Protein Kinase C Signaling Plays a Critical Role in the Regulation of the Developmentally Important TBX2 Gene

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 284, 期 39, 页码 26368-26376

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M109.021360

关键词

-

资金

  1. SA Medical Research Council
  2. National Research Foundation
  3. University of Cape Town

向作者/读者索取更多资源

The mechanism(s) regulating the expression of the TBX2 gene, a key regulator of development, is poorly understood and thus limits an understanding of its function(s). Here we demonstrate that 12-O-tetradecanoylphorbol-13-acetate (TPA) induces TBX2 expression in normal human fibroblasts in a protein kinase C (PKC)-dependent and MAPK-independent manner. Our data further reveal that TPA activates transcription of TBX2 through activating MSK1, which leads to an increase in phosphorylated histone H3 and the recruitment of Sp1 to the TBX2 gene. In addition, TPA was shown to activate MSK1 in a PKC-dependent and MAPK-independent manner. This study is the first to provide evidence that phosphorylation of histone H3 leads to the transcriptional activation of the TBX2 gene and to link MSK1 to PKC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

The palladacycle, BTC2, exhibits anti-breast cancer and breast cancer stem cell activity

Serah Kimani, Suparna Chakraborty, Ikponmwosa Irene, Jo de la Mare, Adrienne Edkins, Andre du Toit, Ben Loos, Angelique Blanckenberg, Annick Van Niekerk, Leticia Costa-Lotufo, K. N. ArulJothi, Selwyn Mapolie, Sharon Prince

Summary: The study investigated the anti-cancer activity of a palladium complex, BTC2, in human breast cancer cells, demonstrating its selectivity, inhibition of cancer cell migration, and suppression of cancer stem cell activity. BTC2 also induced DNA double strand breaks, triggered cell cycle arrests, and activated multiple cell death pathways, showing promising anti-breast cancer activity both in vitro and in vivo.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Environmental Sciences

In vitro antimetastatic activity of Momordica balsamina crude acetone extract in HT-29 human colon cancer cells

Karabo Serala, Paul Steenkamp, Leseilane Mampuru, Sharon Prince, Kgomotso Poopedi, Vusi Mbazima

Summary: The study demonstrated that the crude acetone extract of Momordica balsamina (MBE) inhibited the metastatic ability of HT-29 colorectal cancer (CRC) cells in vitro. MBE consists of a mixture of compounds with cytotoxic effects against HT-29 cells and can suppress reactive oxygen species formation, cell invasion, migration, and adhesion. The antimetastatic effects of MBE were associated with the regulation of various proteins related to cancer metastasis.

ENVIRONMENTAL TOXICOLOGY (2021)

Article Oncology

The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells

Victoria Damerell, Melvin Anyasi Ambele, Shanel Salisbury, Alexis Neumann-Mufweba, Chrisna Durandt, Michael Sean Pepper, Sharon Prince

Summary: Sarcomas are aggressive cancers of mesenchymal origin and their clinical management is complex. This study reveals that the c-Myc/TBX3 pathway may be a key mechanism that transforms mesenchymal stromal/stem cells (MSCs) into sarcomas. TBX3 overexpression promotes cell proliferation, migration, and invasion, which are key processes in sarcomagenesis.

FRONTIERS IN ONCOLOGY (2022)

Article Virology

Cervical cancer therapies: Current challenges and future perspectives

Carly A. Burmeister, Saif F. Khan, Georgia Schafer, Nomonde Mbatani, Tracey Adams, Jennifer Moodley, Sharon Prince

Summary: Cervical cancer is the fourth most common female cancer worldwide, but it is rare in high-income countries with established vaccination and screening programs. However, it remains a deadly disease for women in low- and middle-income countries due to limited resources. Current treatment options include surgery, chemotherapy, and radiotherapy, but there are challenges. Promising new therapies, such as immunotherapies, targeted therapies, combination therapies, and genetic treatment approaches, offer hope for treating cervical cancer.

TUMOUR VIRUS RESEARCH (2022)

Editorial Material Virology

HIV infection and the risk of cancer: tumorigenicity of HIV-1 auxiliary proteins Comment

Shaheen Mowla, Riyaadh Ahmed

FUTURE VIROLOGY (2022)

Article Cell Biology

Strongylopus grayii tadpole blastema extract exerts cytotoxic effects on embryonal rhabdomyosarcoma cells

Vincent Harrison, Saif F. Khan, Victoria Damerell, Jenna Bleloch, Kn ArulJothi, Musalula Sinkala, Katie Lennard, Nicola Mulder, Bridget Calder, Jonathan Blackburn, Sharon Prince

Summary: This study shows that tadpole tail blastema extracts (TAD) from the stream frog have anti-cancer potential against embryonal rhabdomyosarcoma (ERMS) cells. TAD inhibits cell viability, induces senescence and apoptosis, and activates DNA damage and stress signaling pathways. Furthermore, TAD inhibits tumor promoters and proteins required for cancer cell survival.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2022)

Article Chemistry, Inorganic & Nuclear

Synthesis and anticancer evaluation of trinuclear N∧N quinolyl-benzimidazole-based PGM complexes

Nosipho Msimango, Athi Welsh, Sharon Prince, Gregory S. Smith

Summary: This article describes the synthesis, characterization, and cytotoxicity of a novel tris-benzimidazole-quinoline hybrid ligand and its corresponding cationic trimetallic complexes. The complexes show stability in DMSO and exhibit antiproliferative properties against human breast cancer cells, with the ruthenium(II) p-cymene complex being the most active.

INORGANIC CHEMISTRY COMMUNICATIONS (2022)

Article Chemistry, Inorganic & Nuclear

Single crystal investigation, spectroscopic, DFT studies, and in-silico molecular docking of the anticancer activities of acetylacetone coordinated Re(I) tricarbonyl complexes

Amanda-Lee E. Manicum, Hitler Louis, Gideon E. Mathias, Ernest C. Agwamba, Frederick P. Malan, Tomsmith O. Unimuke, Wakopo J. Nzondomyo, Sibusiso A. Sithole, Supratim Biswas, Sharon Prince

Summary: In this study, two neutral complexes were synthesized using acetylacetone and characterized by various methods. The synthesized compounds showed potential as anticancer drugs and exhibited binding affinity to specific receptors.

INORGANICA CHIMICA ACTA (2023)

Article Oncology

TBX3 Promotes Cervical Cancer Proliferation and Migration via HPV E6 and E7 Signaling

Saif F. Khan, Carly A. Burmeister, David J. Scott, Musalula Sinkala, Amsha Ramburan, Hue-Tsi Wu, Georgia Schafer, Arieh A. Katz, Sharon Prince

Summary: Cervical cancer, mainly caused by persistent infection with high-risk strains of HPV, is a leading cause of cancer-related deaths in women globally. This study highlights the upregulation of TBX3 in cervical cancer cell lines and patient tissues, and its association with larger and more invasive tumors. It also reveals the dual role of TBX3 in promoting cell proliferation and migration in HPV-positive cells and inhibiting these processes in HPV-negative cells, with its tumor promoting activity depending on E6/E7.

MOLECULAR CANCER RESEARCH (2023)

Article Chemistry, Inorganic & Nuclear

Polypyridyl coordinated rhenium(I) tricarbonyl complexes as model devices for cancer diagnosis and treatment

Lehlohonolo Moherane, Orbett T. Alexander, Marietjie Schutte-Smith, Robin E. Kroon, Penny P. Mokolokolo, Supratim Biswas, Sharon Prince, Hendrik G. Visser, Amanda-Lee E. Manicum

Summary: This study reports on the solid-state structures, solution-state photoluminescence, and in vitro biological applications of fac-[Re(CO)3(N,N'-Bid)(X)]n complexes. The complexes exhibited excellent luminescent properties, and two of them showed inhibitory effects on breast cancer cells.

POLYHEDRON (2022)

Article Biochemistry & Molecular Biology

DNA-binding affinity and molecular docking studies of the PEGylated binuclear palladacycle, BTC2, an efficient metallodrug against triple-negative breast cancer

Annick van Niekerk, Angelique Blanckenberg, Serah Kimani, Suparna Chakraborty, Sharon Prince, Prinessa Chellan, Selwyn Mapolie

Summary: Triple-negative breast cancer (TNBC) has a low survival rate and current chemotherapy options have severe side effects and drug resistance. Palladium compounds show promise as alternatives with less toxicity and selectivity towards TNBC. This study reports the design and synthesis of benzylidene palladacycles with different phosphine bridging ligands. BTC2 emerges as a more soluble and less toxic compound with effective anticancer properties. It displays multimodal DNA binding properties and can be transported by albumin in mammalian cells.

JOURNAL OF INORGANIC BIOCHEMISTRY (2023)

Article Oncology

Intracellular mechanics and TBX3 expression jointly dictate the spreading mode of melanoma cells in 3D environments

Ghodeejah Higgins, Faatiemah Higgins, Jade Peres, Dirk M. Lang, Tamer Abdalrahman, Muhammad H. Zaman, Sharon Prince, Thomas Franz

Summary: Cell stiffness and TBX3 expression are biomarkers of melanoma metastasis in 2D environments. Soft extracellular environments are more favorable for tumor growth. TBX3 mediates collective cell migration and tumor growth in the early VGP disease stage but plays a lesser role in the later metastatic stage of melanoma.

EXPERIMENTAL CELL RESEARCH (2023)

Article Biology

THE DIARYL-IMIDAZOPYRIDAZINE ANTI-PLASMODIAL COMPOUND, MMV652103, EXHIBITS ANTI-BREAST CANCER ACTIVITY

Alexis Neumann-Mufweba, Serah Kimani, Saif Feroz Khan, Kelly Chibale, Sharon Prince

Summary: Breast cancer is the most common malignancy in women worldwide. Researchers have discovered a compound called MMV652103 that shows potential in the treatment of breast cancer. This compound inhibits oncogenic proteins and displays selective cytotoxicity to breast cancer cells, inhibiting their survival and migration, while also demonstrating a favorable safety profile.

EXCLI JOURNAL (2022)

Article Oncology

Targeting the oncogenic TBX3:nucleolin complex to treat multiple sarcoma subtypes

Tarryn Willmer, Victoria Damerell, Shannon Smyly, Danica Sims, Michelle Du Toit, Stephanie Ncube, Musalula Sinkala, Dhirendra Govender, Edward Sturrock, Jonathan M. Blackburn, Sharon Prince

Summary: The study identifies TBX3 as upregulated in various sarcoma subtypes and requiring nucleolin as a cofactor to promote sarcomagenesis. Disruption of the TBX3-nucleolin interaction by AS1411 shows selective anti-cancer activity in sarcoma cells, providing a novel approach for treating sarcomas.

AMERICAN JOURNAL OF CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

Molecular mechanisms underpinning sarcomas and implications for current and future therapy

Victoria Damerell, Michael S. Pepper, Sharon Prince

Summary: Sarcomas are complex mesenchymal neoplasms with a poor prognosis, originating from mesenchymal stromal/stem cells. Research has focused on identifying molecular markers and mechanisms for targeted therapy in recent years.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

暂无数据